HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Equity Capital Markets

Weimeizi (Guangdong) / Equity Capital Markets

<ul>
<li>WEIMEIZI develops the oral care market by means of large promotion and marketing so as to attract consumers, which helps Saky become one of the top brands in China.</li>
<li>However, with the layout of other long-lasting reputable brands and the entry of new brands, how to maintain the market share in fierce competition has become an important issue.</li>
<li>WEIMEIZI’s leading market position is not solid, unless it could create differentiated products and keep up with industry trends closely. </li>
</ul>


WEIMEIZI develops the oral care market by means of large promotion and marketing so as to attract consumers, which helps Saky become one of the top brands in China.
However, with the layout of other long-lasting reputable brands and the entry of new brands, how to maintain the market share in fierce competition has become an important issue.
WEIMEIZI’s leading market position is not solid, unless it could create differentiated products and keep up with industry trends closely. 


Pre-IPO Weimeizi (Guangdong) - The Market Position Is Not Solid

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Weimeizi (Guangdong) (WMZ HK)

Pre-IPO Weimeizi (Guangdong) - The Market Position Is Not Solid

WEIMEIZI develops oral care market via large promotion, but its market position is not solid due to fierce competition, unless it could create...

Xinyao (Criss) Wang

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)